AP NEWS

Global Influenza Diagnostics Market Report 2018-2023 - Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation & Opportunities for Suppliers - ResearchAndMarkets.com

November 27, 2018

DUBLIN--(BUSINESS WIRE)--Nov 27, 2018--The “2018 Global Influenza Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering.

The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed.

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Influenza tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:

Hospitals Commercial/Private Labs Physician Offices Public Health Labs

Key Topics Covered:

I. Introduction

II. Worldwide Test Overview

Technologies and Instrumentation

A. Background, Diagnostic Tests, Vaccines and Drugs

B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Infectious Disease Automated and Semi-automated Analyzers

C. Emerging Infectious Disease Diagnostic Technologies

1. Molecular Diagnostics

2. Monoclonal Antibodies

3. Immunoassays

4. Differential Light Scattering

5. Information Technology

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. Diagnostic Imaging

11. Gel Microdroplets

12. Others

D. Personal Testing

III. Country Analyses: Sales and Volume Forecasts

IV. Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/Panels

C. Information Technology

D. Auxiliary Products

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

Abbott Affymetrix Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad Cepheid Diamedix/Erba DiaSorin Eiken Chemical Elitech Group Enzo Biochem Fujirebio Grifols Hologic/Gen-Probe ID Biomedical/GSK Kreatech/Leica Lonza Ortho-Clinical Diagnostics Qiagen Roche Scienion Sequenom SeraCare Siemens Takara Bio Thermo Fisher/Life Technology Wallac/PE Wako

For more information about this report visit https://www.researchandmarkets.com/research/chspgn/global_influenza?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005740/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/27/2018 01:20 PM/DISC: 11/27/2018 01:20 PM

http://www.businesswire.com/news/home/20181127005740/en

AP RADIO
Update hourly